House OKs bill for experimental drugs for terminal patients

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Medical Caduceus (Image: MGN Online)

MONTGOMERY, Ala. (AP) – The Alabama House has passed a bill that would give terminally ill patients the right to try experimental drugs.

The bill would authorize access to drugs that have completed a clinical trial but that haven’t been approved for general use by the U.S. Food and Drug Administration. The House passed the legislation in a 97-0 vote Thursday.

Ten-year-old Gabe Griffin inspired the bill.

Griffin has Duchenne muscular dystrophy which causes progressive muscle atrophy and often death by age 25.

Griffin’s father Scott Griffin says he hopes Gabe’s generation might be the first to survive the disease.

House sponsor Rep. April Weaver says Alabama should do everything it can to remove “red tape” for patients.

Senate sponsor Sen. Cam Ward says the bill represents the type of legislation lawmakers should address.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.